organo - ORGJF

ORGJF

Close Chg Chg %
53.03 46.95 88.54%

Closed Market

99.98

+46.95 (88.54%)

Volume: 100.00

Last Updated:

Jan 21, 2026, 11:14 AM EDT

Company Overview: organo - ORGJF

ORGJF Key Data

Open

$99.98

Day Range

99.98 - 99.98

52 Week Range

52.94 - 99.98

Market Cap

$4.91B

Shares Outstanding

45.98M

Public Float

24.90M

Beta

1.25

Rev. Per Employee

N/A

P/E Ratio

26.18

EPS

$4.08

Yield

115.03%

Dividend

$0.60

EX-DIVIDEND DATE

Mar 30, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

ORGJF Performance

No Data Available

ORGJF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About organo - ORGJF

Organo Corp. engages in the manufacture and sale of water purifiers and electrical equipment. It operates through the Water Treatment Engineering and Functional Products segments. The Water Treatment Engineering segment manufactures and sells large-scale water treatment equipment; and provides remodeling, replacement, and maintenance services. The Functional Products segment offers standard water treatment equipment, water treatment chemicals, and food additives. The company was founded on May 1, 1946 and is headquartered in Tokyo, Japan.

ORGJF At a Glance

Organo Corp.
1-2-8 Shinsuna
Tokyo, Tokyo 136-8631
Phone 81-3-5635-5100 Revenue 1.07B
Industry Industrial Machinery Net Income 158.41M
Sector Producer Manufacturing 2025 Sales Growth 2.864%
Fiscal Year-end 03 / 2026 Employees 2,660
View SEC Filings

ORGJF Valuation

P/E Current 26.182
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 12.361
Price to Sales Ratio 1.828
Price to Book Ratio 2.421
Price to Cash Flow Ratio 10.37
Enterprise Value to EBITDA 9.225
Enterprise Value to Sales 1.867
Total Debt to Enterprise Value 0.076

ORGJF Efficiency

Revenue/Employee 402,618.404
Income Per Employee 59,553.464
Receivables Turnover 1.342
Total Asset Turnover 0.854

ORGJF Liquidity

Current Ratio 2.552
Quick Ratio 2.202
Cash Ratio 0.26

ORGJF Profitability

Gross Margin 33.798
Operating Margin 19.061
Pretax Margin 19.819
Net Margin 14.792
Return on Assets 12.637
Return on Equity 21.374
Return on Total Capital 16.487
Return on Invested Capital 20.796

ORGJF Capital Structure

Total Debt to Total Equity 18.797
Total Debt to Total Capital 15.822
Total Debt to Total Assets 11.695
Long-Term Debt to Equity 3.07
Long-Term Debt to Total Capital 2.584
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Organo - ORGJF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
997.36M 977.58M 1.04B 1.07B
Sales Growth
+5.11% -1.98% +6.50% +2.86%
Cost of Goods Sold (COGS) incl D&A
743.61M 719.38M 737.56M 709.00M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
11.85M 13.46M 13.92M 12.63M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+6.14% -3.26% +2.53% -3.87%
Gross Income
253.75M 258.20M 303.59M 361.97M
Gross Income Growth
+2.23% +1.75% +17.58% +19.23%
Gross Profit Margin
+25.44% +26.41% +29.16% +33.80%
2022 2023 2024 2025 5-year trend
SG&A Expense
157.18M 145.89M 147.47M 157.83M
Research & Development
19.10M 19.30M 19.59M 21.34M
Other SG&A
138.08M 126.54M 127.72M 136.49M
SGA Growth
-0.44% -7.18% +1.08% +7.02%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 836.56K
-
EBIT after Unusual Expense
95.73M 112.31M 156.11M 204.14M
Non Operating Income/Expense
18.37M 7.25M 9.18M 9.73M
Non-Operating Interest Income
231.39K 258.37K 955.59K 787.14K
Equity in Earnings of Affiliates
1.42M 1.54M 1.41M 800.26K
Interest Expense
1.13M 1.17M 1.66M 1.61M
Interest Expense Growth
+2.46% +3.85% +41.59% -2.90%
Gross Interest Expense
1.13M 1.17M 1.66M 1.61M
Interest Capitalized
- - - -
-
Pretax Income
112.99M 118.37M 163.65M 212.25M
Pretax Income Growth
+23.61% +4.76% +38.25% +29.70%
Pretax Margin
+11.33% +12.11% +15.72% +19.82%
Income Tax
30.88M 31.52M 43.61M 53.60M
Income Tax - Current - Domestic
26.56M 34.16M 45.03M 53.18M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
4.32M (2.64M) (1.42M) 413.25K
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
1.42M 1.54M 1.41M 800.26K
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
82.11M 86.84M 120.03M 158.65M
Minority Interest Expense
133.49K 250.99K 166.19K 236.14K
Net Income
81.97M 86.59M 119.86M 158.41M
Net Income Growth
+22.91% +5.63% +38.42% +32.16%
Net Margin Growth
+8.22% +8.86% +11.51% +14.79%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
81.97M 86.59M 119.86M 158.41M
Preferred Dividends
- - - -
-
Net Income Available to Common
81.96M 86.59M 119.86M 158.41M
EPS (Basic)
1.7859 1.8881 2.61 3.4461
EPS (Basic) Growth
+22.85% +5.72% +38.23% +32.03%
Basic Shares Outstanding
45.90M 45.86M 45.92M 45.97M
EPS (Diluted)
1.7859 1.8881 2.61 3.4461
EPS (Diluted) Growth
+22.85% +5.72% +38.23% +32.03%
Diluted Shares Outstanding
45.90M 45.86M 45.92M 45.97M
EBITDA
108.42M 125.78M 170.03M 216.77M
EBITDA Growth
+6.55% +16.01% +35.19% +27.48%
EBITDA Margin
+10.87% +12.87% +16.33% +20.24%

Organo in the News